← Leaderboards
Sean Thomas Bailey
Univ Of North Carolina Chapel Hill
$103,209
Attributed
$103,209
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $34.5K · FY2011–13$50K$37.5K$25K$12.5K$0
'11
'12
'13
Funding mix
By agency
NIH$103,209 · 1
By mechanism
F31$103,209 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Ian J Davis$7,130,869
- Zibo Li$7,321,417
- John Christopher Chappell$3,451,472
- Victoria L. Bautch$17,850,903
- Bernard E. Weissman$16,032,468
Others in their field
Top investigators on “Biomarker”
- David R. Weir · University Of Michigan At Ann Arbor$368,126,077
- Leonard Freedman · Leidos Biomedical Research, Inc.$248,231,562
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$217,859,034
- Ralph Parchment · Leidos Biomedical Research, Inc.$186,322,680
- Randall J Bateman · Washington University$182,177,358
- Paul S. Aisen · Cognition Therapeutics, Inc.$182,141,353
Research focus
BiomarkerBlood VesselsCell NucleusCharacteristicsClinical TrialsCohortConventional (Clear Cell) Renal Cell CarcinomaDrug UsageEvaluationFamilyFda ApprovedFluorodeoxyglucose Positron Emission TomographyFunctional ImagingGene ExpressionGene TargetingGenetic TranscriptionHistologyHypoxia Inducible FactorImageImaging ModalityIncidenceInhibitor/AntagonistMalignant NeoplasmsAvidity
Grant awards (3)
Discovery of Molecular and Imaging Biomarkers in RCC patient-Derived Tumorgrafts$34,547
F31 · FY2013 · CA · contact PI
Discovery of Molecular and Imaging Biomarkers in RCC patient-Derived Tumorgrafts$34,547
F31 · FY2012 · CA · contact PI
Discovery of Molecular and Imaging Biomarkers in RCC patient-Derived Tumorgrafts$34,115
F31 · FY2011 · CA · contact PI